Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2021-09-02 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-02 | 2021-09-01 | ACRS | Monahan Joseph | CSO | F - Tax | $17.22 | -1,041 | 86.6K | -1% | -$17.9K |
| D | 2021-09-02 | 2021-09-01 | ACRS | Monahan Joseph | CSO | M - OptEx | — | +2,333 | 87.7K | +3% | — |
| D | 2021-09-02 | 2021-09-01 | ACRS | Monahan Joseph | CSO | M - OptEx | $0.00 | -2,333 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | F | D | 1,041 | $17.22 | 86,634 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-01 | M | A | 2,333 | — | 87,675 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 3 | Derivative | Restricted Stock Units | 2021-09-01 | M | D | 2,333 | $0.00 | 0 | D | — · — to — | 2,333 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F3) The shares underlying these restricted stock units vested on September 1, 2021. |